MAXHEALTH Stock View

Max Healthcare Institute Ltd
stock-view-header

₹ 652.35

icon 7.40 | 1.15
Market Cap ₹( Cr.)
633,970.70
Proj. P/E (x)
48.53
Proj. P/BV (x)
7.01
Proj. ROE (%)
15.55
Proj EV / EBITDA (x)
--
Proj. Revenue ( Cr.)
67,133.27

Stock View

Last Updated On.
26-Nov-2023
 

The average score for Max Healthcare Institute Ltd stands at 8 against 6, three months back.

Max Healthcare Institute Limited is an India-based healthcare company. The Company operates through the Medical and Healthcare Services segment. The Company also operates a homecare business and pathology business under the brand names Max@Home and Max Lab. Max@Home offers health and wellness services at home. Max Lab provides pathology services outside its hospital network. The Company is specialized in providing treatment for cancer care/oncology, cardiac sciences, endocrinology and diabetes, eye care/ophthalmology, gastroenterology, hepatology and endoscopy, laparoscopic/minimal access surgery, neurosciences, liver transplant and biliary sciences, orthopedics and joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery. The Company owns, operates and provides medical services to facilities in Delhi, Mumbai, Punjab, Uttar Pradesh and Uttarakhand. It has approximately 17 healthcare facilities.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.


Technical Data

50 DMA(₹)
583.13
100 DMA(₹)
582.47
200 DMA(₹)
538.58
52 Weeks Range
412.00     665.70

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required